Crosstalk between dendritic cell subsets and implications for dendritic cell-based anticancer immunotherapy

Ghaith Bakdash, Inge Schreurs, Gerty Schreibelt, Jurjen Tel

Research output: Contribution to journalArticleAcademicpeer-review

23 Citations (Scopus)

Abstract

Dendritic cells (DCs) are a family of professional antigen-presenting cells that have an indispensable role in the initiation of innate and adaptive immune responses against pathogens and tumor cells. The DC family is very heterogeneous. Two main types of naturally occurring DCs circulate in peripheral blood, each with its unique phenotypic and functional characteristics: myeloid DCs and plasmacytoid. There is an ample number of studies that have focused on the bi-directional crosstalk between DCs and natural killer cells or T cells. However, the crosstalk among the different DC subsets, in the context of infectious diseases and cancer, has until now not received much attention. Here, we review all available literature that has dealt with the crosstalk between plasmacytoid and myeloid DCs and the potential mode of action. Emphasis will be given to the therapeutic potential of the combination of DC subsets for DC-based immunotherapy.

Original languageEnglish
Pages (from-to)915-926
Number of pages12
JournalExpert Review of Clinical Immunology
Volume10
Issue number7
DOIs
Publication statusPublished - Jul 2014
Externally publishedYes

Keywords

  • Dendritic Cells
  • Humans
  • Immunotherapy
  • Neoplasms
  • Journal Article
  • Research Support, Non-U.S. Gov't
  • Review

Fingerprint

Dive into the research topics of 'Crosstalk between dendritic cell subsets and implications for dendritic cell-based anticancer immunotherapy'. Together they form a unique fingerprint.

Cite this